Sort
15,273 grants matching “antimicrobial resistance”
Subproject 2 C. elegans-Mediated Discovery of Antimicrobial Compounds Against MRSA and VRE
$444,961Frederick M Ausubel · Massachusetts Eye And Ear Infirmary · P01 · FY2016 · AI
Secreted antimicrobial proteins of the intestinal Bacteriodales
$444,871Laurie E Comstock · Brigham And Women'S Hospital · R01 · FY2016 · AI
Type II alveolar epithelial cell-intrinsic IL-1 response in protective immunity against tuberculosis
$444,705Bibhuti Bhusan Mishra · Albany Medical College · R01 · FY2023 · HL
Activation of immune receptor signaling by a sulfated peptide
$444,634Pamela C Ronald · University Of California At Davis · R01 · FY2020 · GM
Targeting the LpqY-SugABC transporter system for synergistic anti-TB compounds
$444,375Lia Danelishvili · Oregon State University · R15 · FY2019 · AI
Streptococcal virulence regulation by a novel intercellular signaling pathway
$444,125Muthiah Kumaraswami · Methodist Hospital Research Institute · R21 · FY2025 · AI
Mechanisms and use of penicillin-binding protein inhibition to optimize cationic peptide anti-MRSA treatment
$444,080Warren E Rose · University Of Wisconsin-Madison · R01 · FY2017 · AI
Health promoting effects of high-polyphenol foods may be mediated through gut microbiome
$444,045Ilya Raskin · Rutgers, The State Univ Of N.J. · R01 · FY2016 · AT
Bacteriophage control of DNA repair in streptococcus pyogenes
$444,000William Michael McShan · University Of Oklahoma Hlth Sciences Ctr · R15 · FY2013 · AI
Examining SecA as a Potential Target for Treating Gram-positive Bacteria
$444,000Binghe Wang · Georgia State University · R56 · FY2014 · AI
Virulence determinants of Fusobacterium nucleatum
$443,896Hung Ton-That · University Of California Los Angeles · R01 · FY2020 · DE
IL-17 Receptor Signaling in the Oral Mucosa
$443,872Sarah L. Gaffen · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · DE
Redox-regulation in Gram-negative Bacteria
$443,840Jan-Ulrik Dahl · Illinois State University · R15 · FY2021 · AI
Functional Interrogation Of Ribosomal Biology Using Continuous Evolution
$443,750Ahmed Hussein Badran · Scripps Research Institute, The · DP5 · FY2021 · OD
The role of neutrophils in the age-driven decline in anti-pneumococcal vaccine responses
$443,703Elsa Bou Ghanem · State University Of New York At Buffalo · R01 · FY2024 · AG
Circumventing Antibiotic Resistance with Novel Gene-Silencing Therapeutics
$443,512David Elihu Greenberg · Ut Southwestern Medical Center · R33 · FY2017 · AI
Regulation of morphogenesis in C. albicans
$443,446James B. Konopka · State University New York Stony Brook · R01 · FY2019 · AI
Regulation of morphogenesis in C. albicans
$443,446James B. Konopka · State University New York Stony Brook · R01 · FY2020 · AI
Regulation of morphogenesis in C. albicans
$443,446James B. Konopka · State University New York Stony Brook · R01 · FY2021 · AI
Subproject 3: Unique Features of Enterococcus that Confer Intrinsic Resistance
$443,287Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · P01 · FY2023 · AI
Molecular basis of intestinal cryptosporidiosis
$443,276Xian-Ming Chen · Rush University Medical Center · R01 · FY2021 · AI
Survival of Neisseria gonorrhoeae after primary human neutrophil challenge
$442,851Alison K Criss · University Of Virginia · R01 · FY2015 · AI
Mechanistic evaluation of broccoli sprout extract in preclinical COPD models
$442,846Shyam Biswal · Johns Hopkins University · R01 · FY2016 · AT
A Pathomimetic Gingiva-on-a-Chip for Assessing Microbiota-Directed Anti-Inflammatory Therapeutics
$442,750Apollo Stacy · Cleveland Clinic Lerner Com-Cwru · R21 · FY2025 · DE
A Trial to Explore the Benefits of Antimicrobial Self-Sanitizing Surfaces on Bio-Burden Levels and Healthcare-Acquired Infections.
$442,710Chetan Jinadatha · Central Texas Veterans Research Foundation · R01 · FY2022 · HS